Autifony
Autifony develops novel pharmaceutical drug for the treatments of hearing loss.
Business Model:
Revenue: $19.3M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Autifony Information
Geographic Data
Address: Stevenage Bioscience Catalyst, Gunnels Wood Road
City: Hertfordshire
State: england
Zip: SG1 2FX
Country: GB
Financial Info
Stage:
series unknown
Raised Last:
$2M
Raised Total:$34M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Autifony develops novel pharmaceutical drug for the treatments of hearing loss.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2017 | Venture Round | 2 | $1.6M |
Dementia Discovery Fund Innovate UK Dementia Discovery Fund Innovate UK |
3/2017 | Grant | $1.6M |
Dementia Discovery Fund |
7/2015 | Series A | $12.3M |
SV Life Sciences Imperial Innovations International Biotechnology Trust UCL Business PLC |
7/2015 | Series A | 4 | $12.4M |
Imperial Innovations Pfizer Venture Investments SV Health Investors UCLB Imperial Innovations Pfizer Venture Investments SV Health Investors UCLB |
8/2011 | Funding Round | 2 | $16.5M |
SV Health Investors Imperial Innovations SV Health Investors Imperial Innovations |
6/2013 | Series A | $5.5M | 8/2011 | Venture Round | $16.5M |
Imperial Innovations SV Life Sciences |
8/2011 | Seed Round | 2 | $16.5M |
Imperial Innovations SV Health Investors Imperial Innovations SV Health Investors |
6/2014 | Grant | $3.7M | 6/2014 | Grant | $3.7M |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
